JNJ

172.24

-0.77%↓

ABBV

197.9

+0.31%↑

AZN

74.9

+1.11%↑

NVS

119.11

+0.89%↑

ABT

129.76

-1.11%↓

JNJ

172.24

-0.77%↓

ABBV

197.9

+0.31%↑

AZN

74.9

+1.11%↑

NVS

119.11

+0.89%↑

ABT

129.76

-1.11%↓

JNJ

172.24

-0.77%↓

ABBV

197.9

+0.31%↑

AZN

74.9

+1.11%↑

NVS

119.11

+0.89%↑

ABT

129.76

-1.11%↓

JNJ

172.24

-0.77%↓

ABBV

197.9

+0.31%↑

AZN

74.9

+1.11%↑

NVS

119.11

+0.89%↑

ABT

129.76

-1.11%↓

JNJ

172.24

-0.77%↓

ABBV

197.9

+0.31%↑

AZN

74.9

+1.11%↑

NVS

119.11

+0.89%↑

ABT

129.76

-1.11%↓

Search

Twist Bioscience Corp

Ouvert

SecteurSoins de santé

27.67 4.02

Résumé

Variation du prix de l'action

24h

Actuel

Min

26.48

Max

28.06

Chiffres clés

By Trading Economics

Revenu

-7.7M

-39M

Ventes

4.1M

93M

Marge bénéficiaire

-42.383

Employés

923

EBITDA

-21M

-46M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+31.34% upside

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-531M

1.8B

Ouverture précédente

23.65

Clôture précédente

27.67

Sentiment de l'Actualité

By Acuity

100%

0%

364 / 374 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Very Strong Bearish Evidence

Twist Bioscience Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

11 août 2025, 17:49 UTC

Principaux Mouvements du Marché

180 Life Sciences Stock Jumps on $156 Million Notes Sale

11 août 2025, 17:18 UTC

Principaux Mouvements du Marché

Tiziana Life Sciences Rises After FDA Approves IND for Foralumab Trial

11 août 2025, 16:25 UTC

Résultats

Correction to Constellation Software 2Q Revenue Rises, Profit Shrinks Article on Aug. 8

11 août 2025, 23:50 UTC

Market Talk

Nikkei May Rise as Yen Weakens -- Market Talk

11 août 2025, 23:42 UTC

Market Talk

Global Energy Roundup: Market Talk

11 août 2025, 23:42 UTC

Market Talk

Woodside's Share Price Implies Lofty Oil Price -- Market Talk

11 août 2025, 23:36 UTC

Market Talk

Gold Edges Higher on Likely Technical Recovery -- Market Talk

11 août 2025, 23:32 UTC

Market Talk

Argosy's New Bull Sees Sentiment Toward REITs Improving -- Market Talk

11 août 2025, 23:02 UTC

Market Talk

RBA Set to Lower OCR With New Forecasts in Focus -- Market Talk

11 août 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

11 août 2025, 20:37 UTC

Résultats
Acquisitions, Fusions, Rachats

Bakkt Holdings: Andy Main Will Step Dn as Co-CEO and Director, Effective Aug 11, and Akshay Naheta Will Assume Role of CEO >BKKT

11 août 2025, 20:37 UTC

Résultats
Acquisitions, Fusions, Rachats

Bakkt Holdings 2Q Rev $577.9M >BKKT

11 août 2025, 20:37 UTC

Résultats
Acquisitions, Fusions, Rachats

Bakkt Holdings: In Upcoming Qtr, Will Conduct Comprehensive Review of Cost Structure to Ensure We Are Optimized, Driving Synergies Across Business, and Accelerating Path to Profitability >BKKT

11 août 2025, 20:22 UTC

Résultats

Exodus Movement: Assets 2,058 Units of Bitcoin Valued at $220.5M, 2,729 Units of Ether Valued at $6.8M, $58.1M in Cash and Cash Equivalents, USD Coin, Treasury Bills as of June 30 >EXOD

11 août 2025, 20:22 UTC

Résultats

Exodus Movement: Monthly Active Users 1.5M at End 2Q, Unchanged From 1.5M as of June 30, 2024 >EXOD

11 août 2025, 20:22 UTC

Résultats

Exodus Movement: Processed Volume $1.38B in 2Q Dn 37% From 1Q, Bitcoin, Tether (TRX Network), Tether (ETH Network), USDC, SOL Top Assets Traded in 2Q >EXOD

11 août 2025, 20:22 UTC

Résultats

Exodus Movement: Digital Assets and Liquid Assets $291.2M >EXOD

11 août 2025, 20:22 UTC

Résultats

Exodus Movement 2Q Rev $25.8M >EXOD

11 août 2025, 20:14 UTC

Market Talk

Canada Dollar Faces Near-Term Weakness on Trade Row, September Rate-Cut Chatter -- Market Talk

11 août 2025, 19:12 UTC

Market Talk

Crude-Oil Futures Edge Up in Rangebound Trade -- Market Talk

11 août 2025, 18:56 UTC

Market Talk

U.S. Natural-Gas Futures Fall on Forecast Loss of Late August Heat -- Market Talk

11 août 2025, 18:31 UTC

Market Talk

Mining Halt Could Lift Lithium Prices in Near Term -- Market Talk

11 août 2025, 17:43 UTC

Market Talk

Freeport-McMoRan Can Push Up Prices, Profits With Copper Tariff Protection -- Market Talk

11 août 2025, 17:28 UTC

Market Talk

Crossborder Trade Tensions Accelerate Softness in Canada Rents -- Market Talk

11 août 2025, 17:16 UTC

Market Talk

Commodity Longs Fall to 11-Month Low -- Market Talk

11 août 2025, 16:42 UTC

Acquisitions, Fusions, Rachats

Adobe Stock Gets a Downgrade. 'AI Is Eating Software,' Analyst Says. -- Barrons.com

11 août 2025, 16:27 UTC

Acquisitions, Fusions, Rachats

BBVA Says Sabadell Offer Remains in Effect

11 août 2025, 16:26 UTC

Acquisitions, Fusions, Rachats

BBVA Previously Said It Won't Withdraw Offer to Buy Sabadell

11 août 2025, 16:25 UTC

Acquisitions, Fusions, Rachats

Banco de Sabadell Announced TSB Sale on July 1

11 août 2025, 16:25 UTC

Acquisitions, Fusions, Rachats

Banco de Sabadell Shareholders Approved TSB Unit Sale on Aug 6

Comparaison

Variation de prix

Twist Bioscience Corp prévision

Objectif de Prix

By TipRanks

31.34% hausse

Prévisions sur 12 Mois

Moyen 36.29 USD  31.34%

Haut 46 USD

Bas 25 USD

Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

8 ratings

5

Achat

2

Maintien

1

Vente

Score Technique

By Trading Central

31.56 / 38.6884Support & Résistance

Court Terme

Very Strong Bearish Evidence

Moyen Terme

Bearish Evidence

Long Terme

Bearish Evidence

Sentiment

By Acuity

364 / 374Classement par Soins de santé

Sentiment de l'Actualité

Très Fortes Indications Baissières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Twist Bioscience Corp

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.